Newstral
Article
Politico.eu on 2023-08-10 18:05
Novo Nordisk prioritizes existing patients for weight-loss drug as demand soars
Related news
- Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales SoarForbes
- Sales skyrocket for weight-loss drug firm Novo Nordiskeuronews
- Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid ShortagesForbes
- Growing demand for weight loss treatments drives sales at drugmaker Novo NordiskShropshire Star
- Novo Nordisk eyes 1,000-job expansion in Johnston County as sales of weight-loss drugs surgeWRAL
- INovo Nordisk results: profits grow by over 30% off the back of weight-loss brand WeGovyinvezz.com
- IEarnings report: Novo Nordisk cashes in on weight loss drug fever with better-than-expected resultsinvezz.com
- MWegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlookmvtelegraph.com
- Weight-Loss Drug Wegovy Launches In U.K. As Shares Of Drugmaker Novo Nordisk Hit New PeakForbes
- MNovo Nordisk weight reduction medicine linked to uncommon eye situation: researchmvtelegraph.com
- Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyForbes
- Weight-loss drug frenzy cements Novo Nordisk as Europe's most valuable company - Fri, 13 Oct 2023 PSTsyndication.washingtonpost.com
- Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings Amid Booming Demand For Weight Loss And Diabetes DrugsForbes
- FNovo Nordisk AS: Novo Nordisk weight loss drug Wegovy approved in Chinaft.com
- FNovo Nordisk AS: Novo Nordisk invests $4bn to expand weight loss drug production in USft.com
- FNovo Nordisk AS: Novo Nordisk raises profit forecast on high demand for weight loss drugsft.com
- Novo Nordisk layoffs bypass Claytonnewsobserver.com
- FNovo Nordisk AS: Novo Nordisk ‘surprised’ by high European demand for weight-loss drugsft.com
- Novo Nordisk AS: Novo Nordisk raises profit guidance as weight-loss drug sales boomFinancial Times